ICD-10 Coding for Invasive Ductal Carcinoma of the Left Breast(C50.0, C50.212D, C50.312)
Learn about the ICD-10 coding and documentation requirements for invasive ductal carcinoma of the left breast, including specific codes and clinical validation criteria.
Complete code families applicable to Invasive Ductal Carcinoma of the Left Breast
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.312 | Malignant neoplasm of upper-outer quadrant of left female breast | Use when the carcinoma is located in the upper-outer quadrant of the left breast. |
|
| C79.51 | Secondary malignant neoplasm of bone | Use when there is confirmed bone metastasis from a primary breast cancer. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutInvasive Ductal Carcinoma of the Left Breast
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Invasive Ductal Carcinoma of the Left Breast.
Using unspecified codes like C50.912
Impact
Clinical: Leads to vague clinical records., Regulatory: Non-compliance with specificity requirements., Financial: Potential for denied claims due to lack of specificity.
Mitigation
Always specify the quadrant and laterality in documentation.
Incorrect quadrant specification
Impact
Reimbursement: May lead to incorrect billing and reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Ensure documentation specifies the exact quadrant of the breast.
Specificity in Breast Cancer Coding
Impact
Risk of audits due to unspecified breast cancer codes.
Mitigation
Ensure all documentation includes specific quadrant and laterality.